{"database": "lobbying", "table": "lobbying_activities", "rows": [[3005542, "94323d03-5f40-4def-959a-1777b50eec88", "Q2", "FORBES-TATE", 400976792, "PHRMA", 2023, "second_quarter", "PHA", "Issues pertaining to prescription drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).", "HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2023-07-16T10:45:24-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3005542"], "units": {}, "query_ms": 40.275992010720074, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}